openPR Logo
Press release

New Report Explores Hottest Trends in Lanreotide Market 2020-2025: Global Key Vendors - IPSEN

06-11-2020 05:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Business Industry Reports

Lanreotide Market

Lanreotide Market

The exclusive research report on the Global Lanreotide Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Lanreotide Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Overview of Global Lanreotide Market:

This report studies the Global Lanreotide Market over the forecast period of 2020 to 2025. The Global Lanreotide Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.

The significant key factors driving the growth of the Global Lanreotide Market are rapid growth in prevalence of Neuroendocrine Tumors (NETs), acromegaly, Cushing syndrome and other related diseases. As per the statistics published in the American Association of Neurological Surgeons, it is estimated that around 10-15 per million people are affected with Cushing’s syndrome each year. In addition, the syndrome commonly affects adults between 20-50 years and is comparatively.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/270490 .

The Global Lanreotide Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Lanreotide Market is sub-segmented into 60 mg, 90 mg, 120 mg and others. On the basis of Application, the Global Lanreotide Market is classified into Hospital, Pharmacy and others.

In terms of the geographic analysis, The Lanreotide Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Lanreotide Market ecosystem results in the increasing adoption of these systems in North America.

Global Lanreotide Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Lanreotide Market

2 To analyze and forecast the size of the Lanreotide Market, in terms of value and volume

3 To analyze opportunities in the Lanreotide Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Lanreotide Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Lanreotide Market

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Lanreotide Market Report 2020” @ https://www.businessindustryreports.com/buy-now/270490/single .

Top Leading Key Manufacturers are: IPSEN and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Top Medical Industry News:

IPSEN (May 23, 2020) - New surveys show over 80% of patients with spasticity and cervical dystonia treated with botulinum toxin-A experience debilitating symptom recurrence - Ipsen today presents the results of two patient surveys. The surveys involved over 400 respondents from five countries, living with spasticity or cervical dystonia and receiving botulinum neurotoxin type A (BoNT-A) injections. The results show that over 80% of respondents experienced debilitating symptom recurrence, and revealed that a lack of long-lasting symptom control between injections has a profound impact on the personal and professional lives of patients.

“The results from these two important patient surveys provide significant insight into the real-life burden of the two conditions; however, they also highlight a worrying disconnect between patients’ treatment expectations and their actual experience. The findings, which build on our growing understanding of spasticity and cervical dystonia, provide us with the potential to unlock meaningful changes in clinical practice,” said Dr Alberto Esquenazi, Department of Physical Medicine and Rehabilitation, Gait and Motion Analysis Laboratory, MossRehab and Albert Einstein Medical Centre, U.S. and lead investigator on the spasticity survey.

The first survey investigated the burden of spasticity on patients’ lives. Of the 210 respondents from France, Germany, Italy, the U.K., and the U.S., 83% reported that symptoms of spasticity returned between two sessions of BoNT-A, with 59% of these patients experiencing that return within three months of their last treatment. Symptom recurrence significantly impacted patients’ quality of life, including sleep, relationships, performance of daily tasks and working lives. In addition, 47% of working patients reported being unable to work when symptoms re-emerge and 45% of working patients felt less efficient at work than before.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Lanreotide in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/270490 .

Major Points in Table of Contents:

Global Lanreotide Market Report 2020

1 Lanreotide Product Definition

2 Global Lanreotide Market Manufacturer Share and Market Overview

3 Manufacturer Lanreotide Business Introduction

4 Global Lanreotide Market Segmentation (Region Level)

5 Global Lanreotide Market Segmentation (Product Type Level)

6 Global Lanreotide Market Segmentation (Industry Level)

7 Global Lanreotide Market Segmentation (Channel Level)

8 Lanreotide Market Forecast 2020-2025

9 Lanreotide Segmentation Product Type

10 Lanreotide Segmentation Industry

11 Lanreotide Cost of Production Analysis

12 Conclusion

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Report Explores Hottest Trends in Lanreotide Market 2020-2025: Global Key Vendors - IPSEN here

News-ID: 2072154 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Lanreotide

Lanreotide Market Size Future Scope, Demands and Projected Industry Growths to 2 …
The global Lanreotide market was valued at approximately USD 1.73 billion in 2024 and is projected to reach USD 5.8 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 6.8% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/lanreotide-market Lanreotide Market Overview: The Lanreotide market is driven by the growing demand for effective treatments for acromegaly and neuroendocrine tumors, two conditions where lanreotide, a somatostatin analog, plays
Global Lanreotide Market Future Prediction Report By 2032
The global lanreotide market was valued at approximately USD 3.2 billion in 2023 and is projected to reach around USD 5.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period from 2024 to 2032. Global Lanreotide Market Overview The global lanreotide market is driven by the increasing prevalence of neuroendocrine tumors and acromegaly, where lanreotide is widely used for treatment. The market
Lanreotide market Worldwide Industry Analysis, Future Demand and Forecast till 2 …
Lanreotide injection is used to treat patients who have acromegaly and who have not responded to surgery or radiation. Lanreotide injection is also used to treat patients who have neuroendocrine tumours of the GI tract or pancreas (GEP-NETs) that have spread or cannot be removed surgically. Lanreotide injection belongs to the somatostatin agonist family of drugs. It works by lowering the number of specific hormones that the body produces. According to
Global and India Lanreotide Injection Market Report & Forecast 2023-2029
Lanreotide Injection Market Analysis Report & Forecast to 2029 - Competitors, Revenue, Market Trends, Share, Size, Growth and Opportunities The Global and United States RFID Lanreotide InjectionMarket Report was published by QYResearch recently. RFID Lanreotide Injectionmarket is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global RFID Lanreotide Injectionmarket will be able to gain the upper hand as they use the report as
Global Lanreotide Market Growth, Size, Share, Industry Report and Forecast 2021- …
The global Lanreotide market is expected to grow at a significant CAGR during the forecast period (2021-2027). Lanreotide injection is used to treat patients who have acromegaly and who have not responded to surgery or radiation. Lanreotide injection is also used to treat patients who have neuroendocrine tumours of the GI tract or pancreas (GEP-NETs) that have spread or cannot be removed surgically. Lanreotide injection belongs to the somatostatin agonist
Lanreotide Market Size to Rapid Growth and Forecast till 2025 | with IPSEN
The report on the global Lanreotide market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the global Lanreotide market. It offers detailed analysis of the competition and leading companies of the global Lanreotide Market. Here, it concentrates